Whitehawk Therapeutics (WHWK) Share-based Compensation (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.17% |
| Dec 31, 2025 | -12.14% |
| Sep 30, 2025 | -11.95% |
| Jun 30, 2025 | 83.75% |
| Mar 31, 2025 | -9.39% |
| Dec 31, 2024 | -27.49% |
| Sep 30, 2024 | -9.93% |
| Jun 30, 2024 | -20.90% |
| Mar 31, 2024 | 15.36% |
| Dec 31, 2023 | 2.03% |
| Sep 30, 2023 | -0.16% |
| Jun 30, 2023 | 11.46% |
| Mar 31, 2023 | -4.53% |
| Dec 31, 2022 | 4.10% |
| Sep 30, 2022 | 23.36% |
| Jun 30, 2022 | 25.49% |
| Mar 31, 2022 | 28.78% |
| Dec 31, 2021 | 113.43% |
| Sep 30, 2021 | 1,561.54% |
| Jun 30, 2021 | 8.33% |
| Mar 31, 2021 | -7.69% |
| Dec 31, 2020 | 14.71% |
| Sep 30, 2020 | -88.97% |
| Jun 30, 2020 | -5.84% |
| Mar 31, 2020 | 141.64% |
| Dec 31, 2019 | -221.75% |
| Sep 30, 2019 | 6.82% |
| Jun 30, 2019 | -2.74% |
| Mar 31, 2019 | -6.93% |
| Dec 31, 2018 | -17.17% |
| Sep 30, 2018 | -8.13% |
| Jun 30, 2018 | -18.71% |
| Mar 31, 2018 | 323.19% |
| Dec 31, 2017 | 100.33% |
| Sep 30, 2017 | 14.20% |
| Jun 30, 2017 | -28.23% |
| Mar 31, 2017 | 19.47% |
| Dec 31, 2016 | 14.59% |
| Sep 30, 2016 | -5.06% |
| Jun 30, 2016 | -4.52% |